Metastatic colorectal cancer
Conditions
Interventions
Case series:TAS-102
Sponsors
Jiangsu Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age = 18 years, regardless of gender; 2. Patients with metastatic colorectal cancer (mCRC) at all stages confirmed by histopathology, cytology and imaging data; 3. According to the doctor's judgment, it is suitable to receive the comprehensive treatment based on TAS-102; 4. Good compliance and voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: 1.Have a serious underlying medical condition that makes it impossible to safely administer trial treatment. Including, but not limited to, active infections requiring systemic therapy: decompensated heart failure (NYHA classification III and IV), unstable angina, acute myocardial infarction and other diseases within 1 month before admission; 2.Other reasons that the researcher determines are not suitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Median progression free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-year overall survival rate;Objective remission rate;Disease control rate;Duration of remission;Time to disease progression;Changes of tumor related markers;Security;1-year median progression free survival; | — |
Countries
China
Contacts
Public ContactGu Yanhong
Department of Oncology, Jiangsu Provincial People's Hospital
Outcome results
None listed